UNCY vs. EVO

Last updated Jun 3, 2026

UNCY (Unicycive Therapeutics Inc) and EVO (Evotec SE ADR) are both stocks. Both are in the Healthcare sector — UNCY in Biotechnology, EVO in Drug Manufacturers - Specialty & Generic. Over the past 3 years, UNCY returned -19.58%/yr vs -36.77%/yr for EVO. At a 0.11 correlation, their price movements are largely independent.

Performance

UNCY vs. EVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Unicycive Therapeutics Inc (UNCY) and Evotec SE ADR (EVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UNCY achieves a 25.30% return, which is significantly higher than EVO's -4.22% return.

UNCY

• 1D: -4.87%
• 1M: -5.74%
• YTD: 25.30%
• 6M: 23.38%
• 1Y: 9.15%
• 3Y*: -19.58%
• 5Y*: —
• 10Y*: —

EVO

• 1D: -3.91%
• 1M: -4.53%
• YTD: -4.22%
• 6M: -8.10%
• 1Y: -25.88%
• 3Y*: -36.77%
• 5Y*: -33.01%
• 10Y*: 2.68%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UNCY vs. EVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
UNCY Unicycive Therapeutics Inc	25.30%	-27.35%	-8.47%	60.69%	-73.79%	-58.80%
EVO Evotec SE ADR	-4.22%	-25.96%	-64.54%	44.99%	-65.94%	9.52%

Correlation

The correlation between UNCY and EVO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.21
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (All Time) Calculated using the full available price history since Jul 13, 2021	0.11

Fundamentals

Market Cap UNCY : $1.73B EVO : $1.05B
EPS UNCY : -$0.37 EVO : -$0.29
PB Ratio UNCY : 45.85 EVO : 1.29
Total Revenue (TTM) UNCY : $0.00 EVO : $786.00M
Gross Profit (TTM) UNCY : $0.00 EVO : $113.49M
EBITDA (TTM) UNCY : -$35.07M EVO : -$34.87M

Return for Risk

UNCY vs. EVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UNCY

UNCY Risk / Return Rank: 48
UNCY Sharpe Ratio Rank: 44
UNCY Sortino Ratio Rank: 49
UNCY Omega Ratio Rank: 52
UNCY Calmar Ratio Rank: 50
UNCY Martin Ratio Rank: 47

EVO

EVO Risk / Return Rank: 21
EVO Sharpe Ratio Rank: 19
EVO Sortino Ratio Rank: 21
EVO Omega Ratio Rank: 21
EVO Calmar Ratio Rank: 21
EVO Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UNCY vs. EVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Unicycive Therapeutics Inc (UNCY) and Evotec SE ADR (EVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UNCY	EVO	Difference
Sharpe ratio Return per unit of total volatility	0.10	-0.49	+0.59
Sortino ratio Return per unit of downside risk	0.78	-0.39	+1.18
Omega ratio Gain probability vs. loss probability	1.12	0.95	+0.17
Calmar ratio Return relative to maximum drawdown	0.40	-0.54	+0.94
Martin ratio Return relative to average drawdown	0.63	-1.02	+1.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UNCY vs. EVO - Sharpe Ratio Comparison

The current UNCY Sharpe Ratio is 0.10, which is higher than the EVO Sharpe Ratio of -0.49. The chart below compares the historical Sharpe Ratios of UNCY and EVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	UNCY	EVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.10	-0.49	+0.59
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.57	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.05	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.27	0.08	-0.36

Drawdowns

UNCY vs. EVO - Drawdown Comparison

The maximum UNCY drawdown since its inception was -95.97%, which is greater than EVO's maximum drawdown of -91.29%. Use the drawdown chart below to compare losses from any high point for UNCY and EVO.

Drawdown Indicators

	UNCY	EVO	Difference
Max Drawdown Largest peak-to-trough decline	-95.97%	-91.29%	-4.68%
Max Drawdown (1Y) Largest decline over 1 year	-58.44%	-47.97%	-10.47%
Max Drawdown (3Y) Largest decline over 3 years	-86.82%	-82.71%	-4.11%
Max Drawdown (5Y) Largest decline over 5 years	—	-91.29%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-91.29%	—
Current Drawdown Current decline from peak	-87.64%	-88.88%	+1.24%
Average Drawdown Average peak-to-trough decline	-82.91%	-33.71%	-49.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.47%	25.12%	+12.35%

Volatility

UNCY vs. EVO - Volatility Comparison

Unicycive Therapeutics Inc (UNCY) has a higher volatility of 19.75% compared to Evotec SE ADR (EVO) at 15.98%. This indicates that UNCY's price experiences larger fluctuations and is considered to be riskier than EVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UNCY	EVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.75%	15.98%	+3.77%
Volatility (6M) Calculated over the trailing 6-month period	46.62%	40.77%	+5.85%
Volatility (1Y) Calculated over the trailing 1-year period	90.19%	53.43%	+36.76%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	119.69%	58.57%	+61.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	119.69%	51.63%	+68.06%

Dividends

UNCY vs. EVO - Dividend Comparison

Neither UNCY nor EVO has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both UNCY and EVO in my portfolio?

UNCY and EVO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UNCY or EVO?

UNCY has higher volatility (19.75%) compared to EVO (15.98%). In terms of maximum drawdown, UNCY dropped -95.97% vs EVO's -91.29%.

Which has better risk-adjusted returns?

UNCY currently has the higher Sharpe Ratio (0.10 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.